Your browser doesn't support javascript.
loading
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.
Manders, Sofie H M; Kievit, Wietske; Adang, Eddy; Brus, Herman L; Moens, Hein J Bernelot; Hartkamp, Andre; Hendriks, Lidy; Brouwer, Elisabeth; Visser, Henk; Vonkeman, Harald E; Hendrikx, Jos; Jansen, Tim L; Westhovens, Rene; van de Laar, Mart A F J; van Riel, Piet L C M.
Afiliação
  • Manders SH; Department of IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Centre, Postbus 9101, Geert Grooteplein Noord 21 (Route 114), 6500 HB, Nijmegen, Netherlands. sofie.manders@radboudumc.nl.
  • Kievit W; Department of Health Evidence, Radboud University Medical Centre, Nijmegen, Netherlands. wietske.kievit@radboudumc.nl.
  • Adang E; Department of Health Evidence, Radboud University Medical Centre, Nijmegen, Netherlands. eddy.adang@radboudumc.nl.
  • Brus HL; Department of Rheumatology, TweeSteden Hospital, Dr. Deelenlaan 5, Tilburg, 5042, AD, Netherlands. hbrus@tsz.nl.
  • Moens HJ; Department of Rheumatology, Ziekenhuisgroep Twente, Zilvermeeuw 1, Almelo, 7609 PP, Netherlands. h.moens@zgt.nl.
  • Hartkamp A; Department of Rheumatology, Jeroen Bosch Hospital, Henri Dunantstraat 1, 's-Hertogenbosch, 5223, GZ, Netherlands. a.hartkamp@jbz.nl.
  • Hendriks L; Department of Rheumatology, Medical Centre Leeuwarden, Henri Dunantweg 2, Leeuwarden, 8934, AD, Netherlands. l.hendriks@znb.nl.
  • Brouwer E; Department of Rheumatology, University Medical Centre Groningen, Hanzeplein 1, Groningen, 9700, RB, Netherlands. e.brouwer@umcg.nl.
  • Visser H; Department of Rheumatology, Rijnstate Hospital, Postbus 9555, Arnhem, 6800, TA, Netherlands. hvisser@alysis.nl.
  • Vonkeman HE; Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Haaksbergerstraat 55, Enschede, 7513, ER, Netherlands. h.vonkeman@mst.nl.
  • Hendrikx J; Department of Rheumatic Diseases, Radboud University Medical Centre, Nijmegen, Netherlands. jos.hendrikx@radboudumc.nl.
  • Jansen TL; Department of Rheumatic Diseases, Radboud University Medical Centre, Nijmegen, Netherlands. tim.jansen@radboudumc.nl.
  • Westhovens R; Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven, Oude Markt 13, Leuven, 3000, Belgium. rene.westhovens@uzleuven.be.
  • van de Laar MA; Department of Rheumatology, University Hospitals Leuven, Oude Markt 13, Leuven, 3000, Belgium. rene.westhovens@uzleuven.be.
  • van Riel PL; Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Haaksbergerstraat 55, Enschede, 7513, ER, Netherlands. m.vandelaar@mst.nl.
Arthritis Res Ther ; 17: 134, 2015 May 22.
Article em En | MEDLINE | ID: mdl-25997746
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Análise Custo-Benefício / Antirreumáticos / Rituximab / Abatacepte Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Análise Custo-Benefício / Antirreumáticos / Rituximab / Abatacepte Idioma: En Ano de publicação: 2015 Tipo de documento: Article